Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2021	Mar. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY	$ 30,409			$ 57,701	$ 2,589
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)	(27,194)
Pursuit Vascular, Inc. [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
CONTINGENT EARN-OUT LIABILITY	$ 26,300	$ 26,300	$ 26,300			$ 26,300
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)		$ 0	$ 0